7Baggers
Quarterly
Annual
    Unit: USD2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 
      
    		                
      revenues:
    		                
      product sales
    		31,862,000 32,462,000 35,137,000 40,083,000 41,769,000 49,863,000 34,279,000 35,430,000 35,546,000 32,149,000 25,997,000 24,831,000 26,405,000 29,815,000 34,266,000 20,165,000 
      royalties and milestones
    		586,000 523,000 490,000 723,000 697,000 487,000 473,000 451,000 992,000 1,188,000 416,000 542,000 434,000 361,000 299,000 452,000 
      total revenues
    		32,448,000 32,985,000 35,627,000 40,991,000 42,466,000 50,350,000 34,212,000 35,131,000 36,538,000 33,328,000 25,472,000 25,373,000 26,839,000 30,176,000 34,565,000 20,617,000 
      yoy
    		-23.59% -34.49% 4.14% 16.68% 16.22% 51.07% 34.31% 38.46% 36.14% 10.45% -26.31% 23.07%     
      qoq
    		-1.63% -7.42% -13.09% -3.47% -15.66% 47.17% -2.62% -3.85% 9.63% 30.84% 0.39% -5.46% -11.06% -12.70% 67.65%  
      costs and expenses:
    		                
      cost of sales
    		11,177,000 9,721,000 7,060,000 4,772,000 5,467,000 6,014,000 4,009,000 4,528,000 4,195,000 4,896,000 3,050,000 3,921,000 3,966,000 6,773,000 6,462,000 5,238,000 
      gross profit
    		21,271,000 23,264,000 28,567,000 36,219,000 36,999,000 44,336,000 30,203,000 30,603,000 32,343,000 28,432,000 22,422,000 21,452,000 22,873,000 23,403,000 28,103,000 15,379,000 
      yoy
    		-42.51% -47.53% -5.42% 18.35% 14.40% 55.94% 34.70% 42.66% 41.40% 21.49% -20.21% 39.49%     
      qoq
    		-8.57% -18.56% -21.13% -2.11% -16.55% 46.79% -1.31% -5.38% 13.76% 26.80% 4.52% -6.21% -2.26% -16.72% 82.74%  
      gross margin %
    		65.55% 70.53% 80.18% 88.36% 87.13% 88.06% 88.28% 87.11% 88.52% 85.31% 88.03% 84.55% 85.22% 77.56% 81.30% 74.59% 
      research and development expenses
    		733,000 1,024,000 1,316,000 503,000          230,000 1,316,000 1,626,000 
      selling, general and administrative expenses
    		18,524,000 23,958,000 21,005,000 16,771,000 16,904,000 13,702,000 11,900,000 10,543,000 10,638,000 13,276,000 9,313,000 26,235,000 7,730,000 23,133,000 25,746,000 28,131,000 
      change in fair value of contingent consideration
    		 -17,414,000 -17,532,000 241,000          -465,250 -1,861,000  
      amortization of intangible assets
    		5,631,000 4,775,000 10,184,000 6,284,000 6,284,000 8,170,000 7,969,000 7,969,000 8,501,000 7,175,000 7,175,000 7,218,000 6,547,000 6,546,000 5,587,000 4,855,000 
      restructuring charges
    		720,000 2,442,000 3,034,000          1,089,000 11,019,000 268,000 6,519,000 
      total costs and expenses
    		36,785,000 65,314,000 263,898,000 28,571,000 37,822,000 39,728,000 27,778,000 24,340,000 24,979,000 25,347,000 19,538,000 37,374,000 19,332,000 65,133,000 39,379,000 46,369,000 
      income from operations
    		-4,337,000 -32,329,000 -228,271,000 12,420,000 4,644,000 10,622,000 6,434,000 10,791,000 11,559,000 7,981,000 5,934,000 -12,001,000 7,507,000 -34,957,000 -4,814,000 -25,752,000 
      yoy
    		-193.39% -404.36% -3647.89% 15.10% -59.82% 33.09% 8.43% -189.92% 53.98% -122.83% -223.27% -53.40%     
      qoq
    		-86.58% -85.84% -1937.93% 167.44% -56.28% 65.09% -40.38% -6.64% 44.83% 34.50% -149.45% -259.86% -121.47% 626.15% -81.31%  
      operating margin %
    		-13.37% -98.01% -640.72% 30.30% 10.94% 21.10% 18.81% 30.72% 31.64% 23.95% 23.30% -47.30% 27.97% -115.84% -13.93% -124.91% 
      other income:
    		                
      debt-related expenses
    		 -2,479,500   -9,918,000            
      interest expense
    		-757,000 -755,000 -752,000 -751,000 -1,122,000 -1,313,000 -2,052,000 -2,269,000 -2,327,000 -2,437,000 -2,495,000 -2,605,000 -2,684,000 -2,598,000 -3,050,000 -1,604,000 
      other gain
    		716,000 1,179,000 138,000 661,000 802,000 -731,000 2,000 -95,000 545,000 -504,000 344,000 137,000 269,000 346,000 253,000  
      total other income
    		-41,000 424,000 -614,000 -90,000 -10,238,000 -2,044,000 -2,050,000 -2,364,000 -1,782,000 -2,941,000 -2,151,000 -2,468,000 -2,415,000 -391,000 -4,658,000 -18,219,000 
      net income before income taxes
    		-4,378,000 -31,905,000 -228,885,000 12,330,000 -5,594,000 8,578,000 4,384,000 8,427,000 9,777,000 5,040,000 3,783,000 -14,469,000 5,092,000 -35,348,000 -9,472,000 -43,971,000 
      income tax benefit
    		-132,000    2,110,000   -593,000  -434,000 -46,000 300,000  10,995,000 -1,050,000 9,472,000 
      net income and comprehensive loss
    		-4,510,000 -57,384,000 -279,544,000 8,470,000 -3,484,000 88,553,000 4,174,000 7,834,000 9,064,000 4,606,000 3,737,000 -14,169,000 4,544,000 -24,353,000 -10,522,000 -34,499,000 
      yoy
    		29.45% -164.80% -6797.27% 8.12% -138.44% 1822.56% 11.69% -155.29% 99.47% -118.91% -135.52% -58.93%     
      qoq
    		-92.14% -79.47% -3400.40% -343.11% -103.93% 2021.54% -46.72% -13.57% 96.79% 23.25% -126.37% -411.82% -118.66% 131.45% -69.50%  
      net income margin %
    		-13.90% -173.97% -784.64% 20.66% -8.20% 175.87% 12.20% 22.30% 24.81% 13.82% 14.67% -55.84% 16.93% -80.70% -30.44% -167.33% 
      basic and diluted net income per share
    		-0.05             -0.01 -0.09  
      shares used in computing basic and diluted net income per share
    		94,980             24,958 119,564  
      other revenue
    		   185,000   -540,000 -750,000  -9,000 -941,000      
      loss on impairment of intangible assets
    		 40,808,000 238,831,000              
      income tax expense
    		 -13,102,250 -50,659,000 -3,860,000  -379,000 -210,000  -713,000    -548,000    
      basic net income per share
    		 -0.32 -3.42 0.15 -0.07 1.88 0.09 0.17 0.2 0.11 0.08 -0.32 0.03   -0.35 
      diluted net income per share
    		 -0.32 -3.42 0.13 -0.07 1.61 0.08 0.16 0.2 0.11 0.08 -0.32 0.03   -0.35 
      shares used in computing basic net income per share
    		 7,965 81,713 56,142 51,005 438 48,180 46,274 45,204 619 44,969 44,706 151,296   98,558 
      shares used in computing diluted net income per share
    		 7,965 81,713 70,144 51,005 4,199 57,386 47,579 46,127 619 45,055 44,706 153,918   98,558 
      fair value of contingent consideration
    		    9,167,000 11,842,000 3,900,000 1,300,000 1,645,000        
      commercialization agreement
    		                
      other income :
    		                
      gain on sale of gralise
    		               -850,000 
      loss on extinguishment of convertible notes
    		               -16,272,000 
      loss on sale of nucynta
    		                
      loss on debt extinguishment
    		                
      gain on sale of nucynta
    		               1,006,000 
      gain on extinguishment of convertible notes
    		             -11,970,000   
      loss on prepayment of senior notes
    		             -2,058,250   
      other loss
    		               -499,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.